XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 29, 2023
Nov. 10, 2022
Aug. 11, 2022
Apr. 30, 2023
Apr. 30, 2022
Apr. 19, 2022
Feb. 23, 2022
Feb. 17, 2022
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
May 31, 2023
Nov. 18, 2022
Aug. 31, 2022
May 24, 2022
Stockholders’ Equity (Details) [Line Items]                                
Common stock, shares authorized             250,000,000   250,000,000 250,000,000   250,000,000        
Preferred stock, shares authorized             10,000,000   10,000,000 10,000,000   10,000,000        
Preferred stock, par value (in Dollars per share)             $ 0.00001   $ 0.00001 $ 0.00001   $ 0.00001        
Common stock, shares issued                 16,930,457 16,930,457   15,724,957        
Common stock, shares outstanding                 16,413,058 16,413,058   15,265,228        
Common stock, voting rights                   one            
Aggregate shares               2,222,222                
Common stock price per share (in Dollars per share)               $ 9                
Underwriting discount percentage             8.00%                  
Net proceeds (in Dollars)             $ 17,100,000                  
Shares of common stock   5,000,000                            
Maximum price per (in Dollars per share)   $ 1                       $ 2    
Repurchased shares                 25,032 57,670            
Aggregate amount (in Dollars)                 $ 26,000 $ 59,000            
Average price per share (in Dollars per share)                   $ 1.02            
Remaining shares                   4,500,000            
Reserved shares of common stock             1,600,000                  
Aggregate shares of common stock         1,180,812                      
Agent fees and other offering expenses (in Dollars)           $ 6,900,000                    
Warrants exercise price (in Dollars per share)                               $ 0.001
Exercise price (in Dollars per share)           $ 6.65                    
Agent fee percentage                   7.50%            
Management fee percentage                   1.00%            
Out of pocket expenses (in Dollars)                   $ 85,000            
Purchase of common stock                   220,997            
Percentage of purchase warrants                   6.00%            
Exercise price, per share (in Dollars per share)                 $ 8.46875 $ 8.46875         $ 2.546  
Warrants issuable shares           70,849       70,849            
Net cash proceeds (in Dollars)                   $ 205,093 $ 51,304          
Warrants exercisable                 646,640 646,640   1,686,640        
Percentage of common stock shares                   6.00%            
Exercise price (in Dollars)                 $ 459              
Contingent warrants issuable                   298,346            
Contingent warrants exchanged                   70,849            
Description of contingent warrant liability                   The remaining 227,497 August Contingent Warrants were measured as a liability upon the close of the August 2022 Private Placement.            
Restricted shares of common stock 3,900,000                              
Commission fixed rate, percentage 3.00%                              
Contingent warrants (in Dollars)                   $ 14,000          
Common stock reserved for issuance                         3,150,000   2,600,000  
Issuance options                   804,938            
Weighted average grant date fair value (in Dollars per share)                   $ 1.08            
Aggregate fair value of stock options vested (in Dollars)                 $ 207,000 $ 479,000            
Description of restricted stock                   On May 9, 2023, the Board’s Compensation Committee approved the issuance of restricted stock, granted under the Company’s 2022 Plan, to the Company’s executive officers, employees, and certain of the Company’s consultants. The restricted shares granted totaled 487,500, of which 150,000, 75,000, and 150,000 were granted to the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer, and Chief Business Officer, respectively. All of the restricted shares granted vest as follows: 50% in October 2023, 25% in August 2024, and 25% in August 2025. In addition, on May 31, 2023, the Board’s Compensation Committee approved the issuance of 25,440 shares of restricted stock, granted to the Company’s non-executive Board members, with full vesting on May 31, 2024.            
Outstanding stock options (in Dollars)                   $ 538,000            
Unvested restricted stock (in Dollars)                   $ 369,000            
Private Placement Warrants [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Reserved shares of common stock           590,406                    
Warrants exercise price (in Dollars per share)                 $ 1.13 $ 1.13            
Preferred stock, shares issued     1,350,000                          
Net cash proceeds (in Dollars)     $ 8,700,000                          
Exercise price (in Dollars)                   $ 3.3938            
Exchanged preferred investment options                   1,289,148            
Exercisable shares of common stock                 5,264,274 5,264,274            
Contingent Warrants [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Contingent warrants                   70,849            
August Private Placement Warrant [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Warrants exercisable                 5,193,425 5,193,425            
Common Stock [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Common stock, shares issued                 16,930,457 16,930,457   15,724,957        
Common stock, shares outstanding                 16,413,058 16,413,058   15,265,228        
Exercise price (in Dollars)                              
Pre-Funded Warrants [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Aggregate shares of common stock     2,333,280     590,406                    
Purchase price per share (in Dollars per share)           $ 6.774                    
Warrants exercise price (in Dollars per share)                 $ 0.001 $ 0.001            
April Private Placement Warrants [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Warrants exercisable                 70,849 70,849            
2019 Equity Incentive Plan [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Reserved shares of common stock                 1,400,000 1,400,000            
Maximum [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Weighted-average period term                   1 year 9 months 10 days            
Minimum [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Weighted-average period term                   1 year 3 months 7 days            
Preferred Investment Options [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Aggregate shares of common stock     4,972,428     1,180,812                    
Purchase price per share (in Dollars per share)     $ 2.715     $ 6.775                    
Preferred investment options exercise price (in Dollars per share)       $ 8.46875                        
Exercise price (in Dollars)                   $ 3.3938            
Preferred Investment Options [Member] | Private Placement Warrants [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Aggregate shares of common stock                   1,180,812            
Purchase price per share (in Dollars per share)     $ 2.714                          
H.C. Wainwright & Co., LLC [Member]                                
Stockholders’ Equity (Details) [Line Items]                                
Agent fee percentage       7.50%                        
Management fee percentage       1.00%                        
Out of pocket expenses (in Dollars)       $ 85,000                        
Purchase of common stock       70,849